Cargando…
Effect of Shenqi compound on inflammatory markers and glycemic measures among diabetes mellitus: A protocol for systematic review and meta-analysis
BACKGROUND: Diabetes is a chronic disease characterized by chronic hyperglycemia, absolute or relative deficiency of insulin secretion, and chronic inflammation. Shenqi compound (SC) is a traditional Chinese medicine formula widely used in the treatment of diabetes and diabetic complications. Althou...
Autores principales: | Yang, Yan, Fu, Xiaoxu, Zhong, Wen, Hu, Zhipeng, Tian, Yuan, Zhou, Hui, Gao, Hong, Xie, Chunguang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7337432/ https://www.ncbi.nlm.nih.gov/pubmed/32629649 http://dx.doi.org/10.1097/MD.0000000000020736 |
Ejemplares similares
-
Treatment of microcirculation dysfunction in type 2 diabetic mellitus with Shenqi compound prescription: A protocol of systematic review and meta-analysis of randomized clinical trials
por: Zhong, Min, et al.
Publicado: (2020) -
Effects of Shenqi compound on intestinal microbial metabolites in patients with type 2 diabetes: A protocol for systematic review and meta analysis
por: Xiong, Ran, et al.
Publicado: (2020) -
The effect of diabetes on mortality of COVID-19: A protocol for systematic review and meta-analysis
por: Yang, Yan, et al.
Publicado: (2020) -
Efficacy and safety of shenqi compound for the treatment of diabetic macroangiopathy: A protocol for systematic review and meta-analysis
por: Hu, Zhipeng, et al.
Publicado: (2020) -
The influence of hypoglycemia and hyperglycemia on the adverse outcome of COVID-19 combined with diabetes mellitus: A protocol for systematic review and meta-analysis
por: Yang, Yan, et al.
Publicado: (2020)